Column Group Opportunity III, LP — SEC Form 4 filings
SEC reporting owner CIK 1931825. 14 Form 4 filings on record with FilingPulse; latest filed 2026-09-08.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-02-14 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 27 legs across 10 filings — 41,595,155 shares, $92,135,342 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 12 legs across 3 filings — 9,400,290 shares, $5,927,199 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 48.
- Largest priced transaction: purchase of 1,437,323 shares @ $18.00 ($25,871,814) in Eikon Therapeutics, Inc., filed 2026-02-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tenaya Therapeutics, Inc. (TNYA) | 10% owner | 5 | 2 legs · 37,936,506 sh · $34,999,998 | 12 legs · 9,400,290 sh · $5,927,199 | 2 |
| Eikon Therapeutics, Inc. (EIKN) | 10% owner | 2 | 4 legs · 2,206,960 sh · $39,150,725 | — | 14 |
| Surrozen, Inc./DE (SRZN) | 10% owner | 6 | 21 legs · 1,451,689 sh · $17,984,619 | — | 18 |
| NGM BIOPHARMACEUTICALS INC (NGM) | 10% owner | 1 | — | — | 14 |
Form 4 filings — Column Group Opportunity III, LP
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-08 | 4 | Eikon Therapeutics, Inc. (EIKN) jointly with Column Group IV GP, LP, Column Group IV-A, LP, Column Group IV, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter | Purchase (P): 89,200 @ $11.56 | EDGAR |
| 2026-02-26 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter | Sale (S): 309,228 @ $0.62 · Sale (S): 349,212 @ $0.62 · Sale (S): 1,649,281 @ $0.56 · Sale (S): 1,862,545 @ $0.56 | EDGAR |
| 2026-02-24 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter | Sale (S): 245,965 @ $0.61 · Sale (S): 277,769 @ $0.61 · Sale (S): 143,709 @ $0.60 · Sale (S): 162,291 @ $0.60 | EDGAR |
| 2026-02-12 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter | Sale (S): 161,422 @ $0.82 · Sale (S): 182,295 @ $0.82 · Sale (S): 1,905,115 @ $0.68 · Sale (S): 2,151,458 @ $0.68 | EDGAR |
| 2026-02-09 | 4 | Eikon Therapeutics, Inc. (EIKN) jointly with Column Group IV GP, LP, Column Group IV-A, LP, Column Group IV, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter | Conversion (C): 1,296,629 · Conversion (C): 1,403,568 · Conversion (C): 110,928 · Conversion (C): 44,249 · Conversion (C): 47,898 · Conversion (C): 3,785 · +11 more | EDGAR |
| 2026-01-20 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, COLUMN GROUP III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter | Purchase (P): 5,590 @ $19.89 · Purchase (P): 6,303 @ $19.89 · Purchase (P): 1,204 @ $20 · Purchase (P): 1,358 @ $20 · Purchase (P): 8,484 @ $19.60 · Purchase (P): 9,568 @ $19.60 | EDGAR |
| 2026-01-15 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, COLUMN GROUP III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter | Purchase (P): 5,861 @ $19.80 · Purchase (P): 6,609 @ $19.80 · Purchase (P): 2,596 @ $19.99 · Purchase (P): 2,927 @ $19.99 | EDGAR |
| 2026-01-08 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, COLUMN GROUP III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter | Purchase (P): 7,097 @ $19.89 · Purchase (P): 8,003 @ $19.89 | EDGAR |
| 2025-12-08 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, COLUMN GROUP III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 2,475 @ $17.35 · Purchase (P): 14,503 @ $19.54 · Purchase (P): 2,791 @ $17.35 · Purchase (P): 16,381 @ $19.54 | EDGAR |
| 2025-11-17 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, COLUMN GROUP III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 148,150 @ $12.65 · Purchase (P): 167,307 @ $12.65 | EDGAR |
| 2025-03-28 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, COLUMN GROUP III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 323,886 @ $11.60 · Purchase (P): 365,769 @ $11.60 · Purchase (P): 344,827 @ $11.60 · Code (H): 90,897 (derivative) · Purchase (P): 90,897 (derivative) · Code (H): 102,651 (derivative) · +15 more | EDGAR |
| 2025-03-07 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 35,714,284 @ $0.70 · Purchase (P): 35,714,284 (derivative) · Purchase (P): 17,857,142 (derivative) | EDGAR |
| 2024-04-08 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III GP, LP | Disposition to issuer (D): 949,862 · Disposition to issuer (D): 2,650,177 · Disposition to issuer (D): 90,442 · Disposition to issuer (D): 11,103,333 · Disposition to issuer (D): 858,035 · Disposition to issuer (D): 968,990 · +8 more | EDGAR |
| 2024-02-14 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 2,222,222 @ $4.50 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1931825 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →